Joy N. Tsai

2.6k total citations · 1 hit paper
27 papers, 1.8k citations indexed

About

Joy N. Tsai is a scholar working on Orthopedics and Sports Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Joy N. Tsai has authored 27 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Orthopedics and Sports Medicine, 20 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Joy N. Tsai's work include Bone health and osteoporosis research (22 papers), Bone health and treatments (19 papers) and Bone Metabolism and Diseases (14 papers). Joy N. Tsai is often cited by papers focused on Bone health and osteoporosis research (22 papers), Bone health and treatments (19 papers) and Bone Metabolism and Diseases (14 papers). Joy N. Tsai collaborates with scholars based in United States, Australia and Israel. Joy N. Tsai's co-authors include Benjamin Z. Leder, Hang Lee, Sherri‐Ann M. Burnett‐Bowie, Robert M. Neer, Alexander V. Uihlein, Matthew B. Greenblatt, Marc N. Wein, Paul Wallace, Elizabeth McKay and Yuli Zhu and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Joy N. Tsai

26 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial

2015 380 citations Benjamin Z. Leder, Joy N. Tsai et al. The Lancet profile →

Peers

Joy N. Tsai

OSM

ONCOL

SURGE

PFM

Cassandra E. Milmont United States

Matt Austin United States

Jackie A. Clowes United Kingdom

Christopher Recknor United States

Robin K. Dore United States

Silvano Adami Italy

Ivo Valter United States

D. Wattie New Zealand

D Ethgen Belgium

Charlotte Ejersted Denmark

Cassandra E. Milmont United States

Joy N. Tsai

1.0k ×0.8

OSM

842 ×0.8

ONCOL

852 ×0.9

210 ×0.8

SURGE

158 ×1.2

PFM

Citations per year, relative to Joy N. Tsai Joy N. Tsai (= 1×) peers Cassandra E. Milmont

Countries citing papers authored by Joy N. Tsai

Since Specialization

Citations

This map shows the geographic impact of Joy N. Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joy N. Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joy N. Tsai more than expected).

Fields of papers citing papers by Joy N. Tsai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joy N. Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joy N. Tsai. The network helps show where Joy N. Tsai may publish in the future.

Co-authorship network of co-authors of Joy N. Tsai

This figure shows the co-authorship network connecting the top 25 collaborators of Joy N. Tsai. A scholar is included among the top collaborators of Joy N. Tsai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joy N. Tsai. Joy N. Tsai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ramchand, Sabashini K., Joy N. Tsai, Yingshe Zhao, et al.. (2025). Comparative bone histomorphometry effects of combined denosumab and teriparatide vs monotherapy in postmenopausal women with osteoporosis: a randomized controlled trial. Journal of Bone and Mineral Research.

Ramchand, Sabashini K., et al.. (2023). The comparison of alendronate and raloxifene after denosumab (CARD) study: A comparative efficacy trial. Osteoporosis International. 35(2). 255–263. 8 indexed citations

Lee, Dong Hwan, Joy N. Tsai, E. Sandra Chocrón, et al.. (2022). Gut- and oral-dysbiosis differentially impact spinal- and bulbar-onset ALS, predicting ALS severity and potentially determining the location of disease onset. BMC Neurology. 22(1). 62–62. 33 indexed citations

Ramchand, Sabashini K., et al.. (2020). Effects of Combination Denosumab and High-Dose Teriparatide Administration on Bone Microarchitecture and Estimated Strength: The DATA-HD HR-pQCT Study. Journal of Bone and Mineral Research. 36(1). 41–51. 10 indexed citations

Ramchand, Sabashini K., et al.. (2020). Efficacy of Zoledronic Acid in Maintaining Areal and Volumetric Bone Density After Combined Denosumab and Teriparatide Administration: DATA-HD Study Extension. Journal of Bone and Mineral Research. 36(5). 921–930. 23 indexed citations

Ramchand, Sabashini K., et al.. (2020). The Effect of Zoledronic Acid on Bone Microarchitecture and Strength after Denosumab and Teriparatide Administration: DATA-HD Study Extension. Journal of Bone and Mineral Research. 38(1). 26–34. 4 indexed citations

Tsai, Joy N., et al.. (2019). Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trial. The Lancet Diabetes & Endocrinology. 7(10). 767–775. 47 indexed citations

Ramchand, Sabashini K., et al.. (2019). Bone Mineral Density Response With Denosumab in Combination With Standard or High-Dose Teriparatide: The DATA-HD RCT. The Journal of Clinical Endocrinology & Metabolism. 105(3). 890–897. 9 indexed citations

Loscalzo, Joseph, Nathalie Roy, Ravi V. Shah, et al.. (2018). Case 8-2018: A 55-Year-Old Woman with Shock and Labile Blood Pressure. New England Journal of Medicine. 378(11). 1043–1053. 14 indexed citations

10.

Tsai, Joy N., et al.. (2017). Effects of Teriparatide, Denosumab, or Both on Spine Trabecular Microarchitecture in DATA-Switch: a Randomized Controlled Trial. Journal of Clinical Densitometry. 20(4). 507–512. 32 indexed citations

11.

Leder, Benjamin Z., et al.. (2017). Importance of prompt antiresorptive therapy in postmenopausal women discontinuing teriparatide or denosumab: The Denosumab and Teriparatide Follow-up study (DATA-Follow-up). Bone. 98. 54–58. 81 indexed citations

12.

Tsai, Joy N., et al.. (2017). Three financial regulators issue reports on product and service innovations. Journal of Investment Compliance. 18(1). 84–91. 7 indexed citations

13.

Tsai, Joy N., Alexander V. Uihlein, Sherri‐Ann M. Burnett‐Bowie, et al.. (2016). Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study). The Journal of Clinical Endocrinology & Metabolism. 101(5). 2023–2030. 79 indexed citations

14.

Leder, Benjamin Z., Joy N. Tsai, Robert M. Neer, et al.. (2016). Response to Therapy With Teriparatide, Denosumab, or Both in Postmenopausal Women in the DATA (Denosumab and Teriparatide Administration) Study Randomized Controlled Trial. Journal of Clinical Densitometry. 19(3). 346–351. 22 indexed citations

15.

Greenblatt, Matthew B., Joy N. Tsai, & Marc N. Wein. (2016). Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease. Clinical Chemistry. 63(2). 464–474. 250 indexed citations

16.

Tsai, Joy N., Yuli Zhu, Hang Lee, et al.. (2015). Comparative Resistance to Teriparatide-Induced Bone Resorption With Denosumab or Alendronate. The Journal of Clinical Endocrinology & Metabolism. 100(7). 2718–2723. 7 indexed citations

17.

Leder, Benjamin Z., Joy N. Tsai, Alexander V. Uihlein, et al.. (2015). Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial. The Lancet. 386(9999). 1147–1155. 380 indexed citations breakdown →

18.

Tsai, Joy N., Alexander V. Uihlein, Sherri‐Ann M. Burnett‐Bowie, et al.. (2014). Comparative Effects of Teriparatide, Denosumab, and Combination Therapy on Peripheral Compartmental Bone Density, Microarchitecture, and Estimated Strength: the DATA-HRpQCT Study. Journal of Bone and Mineral Research. 30(1). 39–45. 95 indexed citations

19.

Diem, Susan J., Hadine Joffe, Joseph C. Larson, et al.. (2014). Effects of Escitalopram on Markers of Bone Turnover: A Randomized Clinical Trial. The Journal of Clinical Endocrinology & Metabolism. 99(9). E1732–E1737. 26 indexed citations

20.

Tsai, Joy N., Alexander V. Uihlein, Hang Lee, et al.. (2013). Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial. The Lancet. 382(9886). 50–56. 354 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact